(Reuters) - The U.S. Food and Drug Administration is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine, lowering the...
By Julie Steenhuysen and Manojna Maddipatla (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday set an Oct. 16 deadline for states to submit plans for...
By Steve Scherer OTTAWA (Reuters) - Canada is facing a surge in COVID-19 cases that risks ballooning to higher levels than were seen during the first wave of the pandemic in the...
Amid the recent declines in broader markets, a blockbuster stock debut has been making headlines: cloud-based data-warehousing firm Snowflake (NYSE:SNOW).While the company priced...
The COVID-19 pandemic has created several equity market winners, including pharma giant AstraZeneca (LON:AZN) (NYSE:AZN). The company, along with its partner Oxford University, is...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Strong Buy||Buy||Strong Buy||Buy|
|Technical Indicators||BUY||BUY||Strong Buy||Strong Buy||Strong Buy|
|Summary||Buy||Strong Buy||Strong Buy||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish doji Star||30||Current|
|Three Black Crows||15||2||Sep 22, 2020 03:15PM|
|Dark Cloud Cover||30||3||Sep 22, 2020 02:00PM|
|Advance Block Bearish||1D||4||Sep 16, 2020|
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.Read More
|Cyprus Securities and Exchange Commission (Cyprus), Australian Securities and Investments Commission (Australia), International Financial Services Commission (Belize)||$5||Start Trading|
|Securities Commission of The Bahamas (Bahamas), The Financial Conduct Authority (United Kingdom)||$50||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.